GlassScriptPhysician profile
Pratyusha Parava
NPI 1144523549
$606.96
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $32.00 · 2022: $78.99 · 2023: $141 · 2024: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $163.98 | 2020-2024 | Livdelzi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.56 | 2019-2024 | Xifaxan |
| Abbvie INC. | $59.96 | 2020-2022 | |
| Redhill Biopharma INC. | $48.46 | 2022-2023 | Aemcolo, Movantik, Talicia |
| Pfizer INC. | $42.53 | 2019-2023 | |
| Phathom Pharmaceuticals, INC. | $29.50 | 2024 | Voquezna |
| Intercept Pharmaceuticals, INC. | $27.41 | 2022-2023 | Ocaliva |
| Celgene Corporation | $22.48 | 2023 | Zeposia |
| Ardelyx, INC. | $20.09 | 2024 | Ibsrela |
| Mauna Kea Technologies, INC. | $18.69 | 2019 | |
| Medtronic Minimed, INC. | $18.06 | 2019 | |
| Amarin Pharma, INC. | $17.29 | 2019 | |
| Allergan, INC. | $16.61 | 2019 | |
| Novo Nordisk INC | $15.90 | 2019 | |
| Janssen Biotech, INC. | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pratyusha Parava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.